ORLANDO, FL / ACCESSWIRE / May 6, 2022 / Costas, Inc. CSSI, Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI): http://www.otcmarkets.com/stock/CSSI/profile.
COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. As previously announced, on February 28th, 2022, the shareholders of Standard Dental Labs Inc. (“SDL”) voted unanimously in favor of accepting an offer from CSSI to acquire its assets. The Company is pleased to announce the parties have entered into a formal acquisition agreement, which is expected to close in the coming days. The completion of this acquisition will cement the Company’s entry into the dental lab industry, paving the way for future acquisitions and consolidations in the industry.
The business model acquired from SDL, a company incorporated in Wyoming in 2019, and controlled by Mr. Brooks, the Company’s CEO, has developed branding and a detailed business plan to facilitate the acquisition of small to medium sized dental labs, of which there are thousands in the United States. Similar models have been extensively used in the medical clinic and dental clinic industries over the past 30 years, but dental laboratories remain highly fragmented. “Consolidating small, privately owned labs into larger, regionally managed facilities will bring economies of scale, and enhance competitiveness and product quality in regional markets.” said Costas CEO, James Brooks.
SDL has been actively looking for dental lab owners interested in selling their labs over the recent months. With the recently acquired consolidation model and ready to launch branding, the Company expects to identify several suitable acquisition targets in the coming weeks and months, with the goal of becoming one of the largest operators in the industry. “There’s no faster way to grow than through acquisition, and this industry, in particular, remains unsophisticated in the public sector.”, added Brooks.
Consolidation of this industry, currently represented by 7,000+ privately owned businesses, is now the Company’s focus. The acquired business model will allow the Company to quickly identify suitable targets, to build and scale in order to become regionally competitive. In the process, the Company will be positioning itself as a leader in setting new standards for the dental lab industry.
Acquiring cash flowing, and profitable businesses with a financial track record, is Standard Dental Labs business strategy. The dental lab industry as a whole is estimated to be a $10B market in the US alone in 2022 (source: Grandview Research, Aug. 2021), but is growing steadily.
About Costas: https://costas-inc.com/about-us
FORWARD LOOKING STATEMENTS:
This press release and the statements of representatives of Costas, Inc. (the “Company”) related thereto contain, or may contain, among other things, “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are “forward-looking statements,” including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as “guidance,” “projects,” “may,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “ultimately” or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results (including, without limitation, Costas’ ability to advance its business, generate revenue and profit and operate as a public company) could differ materially from those stated or anticipated in these forward-looking statements as a result of a variety of factors, including factors and risks discussed in the periodic reports that the Company files with OTC Markets (Pink Sheets). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.
For further information contact:
Costas Corporate Phone Number:
SOURCE: Costas, Inc.
View source version on accesswire.com: